These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31570695)

  • 1. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
    Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019.
    van der Straten L; Levin MD; Dinnessen MAW; Visser O; Posthuma EFM; Doorduijn JK; Langerak AW; Kater AP; Dinmohamed AG
    Blood Cancer J; 2023 Jan; 13(1):15. PubMed ID: 36635262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
    van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
    Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
    Ailawadhi S; Ravelo A; Ng CD; Shah B; Lamarre N; Wang R; Eakle K; Biondo JM
    J Comp Eff Res; 2024 Feb; 13(2):e230119. PubMed ID: 38294335
    [No Abstract]   [Full Text] [Related]  

  • 10. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
    Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
    Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z; Liu L; Leng K; Shi G
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second cancer after chronic lymphocytic leukemia.
    Schöllkopf C; Rosendahl D; Rostgaard K; Pipper C; Hjalgrim H
    Int J Cancer; 2007 Jul; 121(1):151-6. PubMed ID: 17351903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
    Jiang S; Jiang H; Sun L; Luo Z
    Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.